January 27th, 2025 |
John Green |
Chief Financial Officer |
Stock Award
|
270.00K |
$2.40M |
270.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
270000 |
$8.89 |
$2.40M |
|
January 27th, 2025 |
Cole Pinnow |
Chief Commercial Officer |
Stock Award
|
240.00K |
$2.13M |
240.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
240000 |
$8.89 |
$2.13M |
|
January 27th, 2025 |
John Robinson |
Chief Scientific Officer |
Stock Award
|
270.00K |
$2.40M |
270.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
270000 |
$8.89 |
$2.40M |
|
January 27th, 2025 |
Jessica Sachs |
Chief Medical Officer |
Stock Award
|
270.00K |
$2.40M |
270.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
270000 |
$8.89 |
$2.40M |
|
January 27th, 2025 |
Andrew Robbins |
Director, Officer: President And CEO |
Stock Award
|
915.00K |
$8.13M |
915.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
915000 |
$8.89 |
$8.13M |
|
January 27th, 2025 |
Evan Kearns |
Chief Legal Officer |
Stock Award
|
230.00K |
$2.04M |
230.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
230000 |
$8.89 |
$2.04M |
|
January 15th, 2025 |
Cole Pinnow |
Chief Commercial Officer |
Purchase
|
43.75K |
$332.41K |
45.85K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Purchase
|
43750 |
$7.60 |
$332.41K |
|
January 3rd, 2025 |
Karen Ferrante |
Director |
Stock Award
|
2.79K |
$21.72K |
2.79K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
2785 |
$7.80 |
$21.72K |
|
October 2nd, 2024 |
Karen Ferrante |
Director |
Stock Award
|
2.03K |
$21.87K |
2.03K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
2034 |
$10.75 |
$21.87K |
|
July 2nd, 2024 |
Karen Ferrante |
Director |
Stock Award
|
2.46K |
$22.01K |
2.46K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
2462 |
$8.94 |
$22.01K |
|
June 13th, 2024 |
Christopher Cain |
Director |
Stock Award
|
44.70K |
$398.72K |
44.70K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
44700 |
$8.92 |
$398.72K |
|
June 13th, 2024 |
Matthew Ros |
Director |
Stock Award
|
44.70K |
$398.72K |
44.70K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
44700 |
$8.92 |
$398.72K |
|
June 13th, 2024 |
Karen Ferrante |
Director |
Stock Award
|
44.70K |
$398.72K |
44.70K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
44700 |
$8.92 |
$398.72K |
|
June 13th, 2024 |
Peter Harwin |
Director |
Stock Award
|
44.70K |
$398.72K |
44.70K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
44700 |
$8.92 |
$398.72K |
|
June 13th, 2024 |
Todd Shegog |
Director |
Stock Award
|
44.70K |
$398.72K |
44.70K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
44700 |
$8.92 |
$398.72K |
|
June 13th, 2024 |
Arlene Morris |
Director |
Stock Award
|
44.70K |
$398.72K |
44.70K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
44700 |
$8.92 |
$398.72K |
|
June 12th, 2024 |
Funds Fairmount |
Director |
Exercise
|
1.50M |
$1.50K |
6.23M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
1500000 |
$0.00 |
$1.50K |
Series B Convertible Preferred Stock |
Exercise/Conversion
|
1500 |
$0.00 |
$- |
|
May 29th, 2024 |
Cole Pinnow |
Chief Commercial Officer |
Stock Award
|
525.00K |
$4.32M |
525.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
525000 |
$8.22 |
$4.32M |
|
May 29th, 2024 |
Cole Pinnow |
Chief Commercial Officer |
|
- |
$- |
700 |
Form 3
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
|
0 |
$0.00 |
$- |
|
April 2nd, 2024 |
Karen Ferrante |
Director |
Stock Award
|
3.21K |
$22.17K |
3.21K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
3213 |
$6.90 |
$22.17K |
|
April 1st, 2024 |
Funds Fairmount |
Director |
Other
|
597.53K |
$- |
4.73M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Other
|
286851 |
$0.00 |
$- |
Series A Convertible Preferred Stock |
Other
|
11914 |
$0.00 |
$- |
Series A Convertible Preferred Stock |
Other
|
11914 |
$0.00 |
$- |
Common Stock |
Other
|
286851 |
$0.00 |
$- |
|
February 16th, 2024 |
Funds Fairmount |
10 Percent Owner |
Stock Award
|
1.17M |
$8.75M |
4.44M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
1166666 |
$7.50 |
$8.75M |
Series B Convertible Preferred Stock |
Stock Award
|
1500 |
$0.00 |
$- |
|
January 25th, 2024 |
John Robinson |
Chief Scientific Officer |
Stock Award
|
300.00K |
$1.39M |
300.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
300000 |
$4.63 |
$1.39M |
|
January 25th, 2024 |
Evan Kearns |
Chief Legal Officer |
Stock Award
|
255.00K |
$1.18M |
255.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
255000 |
$4.63 |
$1.18M |
|
January 25th, 2024 |
Jessica Sachs |
Chief Medical Officer |
Stock Award
|
300.00K |
$1.39M |
300.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
300000 |
$4.63 |
$1.39M |
|
January 25th, 2024 |
Andrew Robbins |
Director, Officer: President And CEO |
Stock Award
|
1.10M |
$5.09M |
1.10M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
1100000 |
$4.63 |
$5.09M |
|
January 25th, 2024 |
John Green |
Chief Financial Officer |
Stock Award
|
300.00K |
$1.39M |
300.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
300000 |
$4.63 |
$1.39M |
|
January 4th, 2024 |
Karen Ferrante |
Director |
Stock Award
|
3.30K |
$20.58K |
3.30K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
3298 |
$6.24 |
$20.58K |
|
January 4th, 2024 |
Matthew Ros |
Director |
Stock Award
|
3.05K |
$19.04K |
3.05K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
3051 |
$6.24 |
$19.04K |
|
October 3rd, 2023 |
Matthew Ros |
Director |
Stock Award
|
2.17K |
$20.72K |
2.17K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
2170 |
$9.55 |
$20.72K |
|
October 3rd, 2023 |
Karen Ferrante |
Director |
Stock Award
|
2.35K |
$22.39K |
2.35K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
2345 |
$9.55 |
$22.39K |
|
July 5th, 2023 |
Karen Ferrante |
Director |
Stock Award
|
1.88K |
$22.53K |
1.88K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
1884 |
$11.96 |
$22.53K |
|
July 5th, 2023 |
Matthew Ros |
Director |
Stock Award
|
1.74K |
$20.85K |
1.74K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
1743 |
$11.96 |
$20.85K |
|
June 13th, 2023 |
Funds Fairmount |
10 Percent Owner |
Purchase
|
800.00K |
$9.60M |
3.27M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Purchase
|
800000 |
$12.00 |
$9.60M |
|
June 8th, 2023 |
Arlene Morris |
Director |
Stock Award
|
36.70K |
$429.39K |
36.70K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
36700 |
$11.70 |
$429.39K |
|
June 8th, 2023 |
Christopher Cain |
Director |
Stock Award
|
36.70K |
$429.39K |
36.70K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
36700 |
$11.70 |
$429.39K |
|
June 8th, 2023 |
Karen Ferrante |
Director |
Stock Award
|
36.70K |
$429.39K |
36.70K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
36700 |
$11.70 |
$429.39K |
|
June 8th, 2023 |
Todd Shegog |
Director |
Stock Award
|
36.70K |
$429.39K |
36.70K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
36700 |
$11.70 |
$429.39K |
|
June 8th, 2023 |
Matthew Ros |
Director |
Stock Award
|
36.70K |
$429.39K |
36.70K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
36700 |
$11.70 |
$429.39K |
|
June 8th, 2023 |
Peter Harwin |
Director |
Stock Award
|
36.70K |
$429.39K |
36.70K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
36700 |
$11.70 |
$429.39K |
|
April 4th, 2023 |
Karen Ferrante |
Director |
Stock Award
|
2.05K |
$22.07K |
2.05K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
2053 |
$10.75 |
$22.07K |
|
April 4th, 2023 |
Matthew Ros |
Director |
Stock Award
|
1.90K |
$20.43K |
1.90K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
1900 |
$10.75 |
$20.43K |
|
February 15th, 2023 |
John Robinson |
Chief Scientific Officer |
Stock Award
|
160.00K |
$2.18M |
160.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
160000 |
$13.63 |
$2.18M |
|
February 15th, 2023 |
Evan Kearns |
Chief Legal Officer |
Stock Award
|
140.00K |
$1.91M |
140.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
140000 |
$13.63 |
$1.91M |
|
February 15th, 2023 |
Jessica Sachs |
Chief Medical Officer |
Stock Award
|
160.00K |
$2.18M |
160.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
160000 |
$13.63 |
$2.18M |
|
February 15th, 2023 |
John Green |
Chief Financial Officer |
Stock Award
|
150.00K |
$2.04M |
150.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
150000 |
$13.63 |
$2.04M |
|
February 15th, 2023 |
Andrew Robbins |
Director, Officer: President And CEO |
Stock Award
|
525.00K |
$7.16M |
525.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
525000 |
$13.63 |
$7.16M |
|
January 4th, 2023 |
Matthew Ros |
Director |
Stock Award
|
1.79K |
$12.88K |
1.79K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
1792 |
$7.19 |
$12.88K |
|
January 4th, 2023 |
Karen Ferrante |
Director |
Stock Award
|
1.86K |
$13.38K |
1.86K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
1862 |
$7.19 |
$13.38K |
|
October 4th, 2022 |
Matthew Ros |
Director |
Stock Award
|
1.42K |
$12.88K |
1.42K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
1419 |
$9.08 |
$12.88K |
|
October 4th, 2022 |
Karen Ferrante |
Director |
Stock Award
|
1.47K |
$13.38K |
1.47K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
1474 |
$9.08 |
$13.38K |
|
July 5th, 2022 |
Karen Ferrante |
|
Stock Award
|
2.28K |
$13.38K |
2.28K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
2279 |
$5.87 |
$13.38K |
|
July 5th, 2022 |
Karen Ferrante |
Director |
Stock Award
|
2.28K |
$21.40K |
2.28K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
2279 |
$9.39 |
$21.40K |
|
July 5th, 2022 |
Matthew Ros |
|
Stock Award
|
2.19K |
$12.88K |
2.19K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
2194 |
$5.87 |
$12.88K |
|
July 5th, 2022 |
Matthew Ros |
Director |
Stock Award
|
2.19K |
$20.60K |
2.19K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
2194 |
$9.39 |
$20.60K |
|
July 1st, 2022 |
Jessica Sachs |
Chief Medical Officer |
Stock Award
|
622 |
$4.60K |
622 |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
622 |
$7.40 |
$4.60K |
|
June 21st, 2022 |
Funds Fairmount |
|
Purchase
|
1.20M |
$9.90M |
2.47M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Purchase
|
1200000 |
$8.25 |
$9.90M |
|
June 9th, 2022 |
Karen Ferrante |
|
Stock Award
|
30.70K |
$- |
30.70K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
30700 |
$0.00 |
$- |
|
June 9th, 2022 |
Karen Ferrante |
Director |
Stock Award
|
30.70K |
$140.91K |
30.70K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
30700 |
$4.59 |
$140.91K |
|
June 9th, 2022 |
Arlene Morris |
|
Stock Award
|
30.70K |
$- |
30.70K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
30700 |
$0.00 |
$- |
|
June 9th, 2022 |
Matthew Ros |
|
Stock Award
|
30.70K |
$- |
30.70K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
30700 |
$0.00 |
$- |
|
June 9th, 2022 |
Matthew Ros |
Director |
Stock Award
|
30.70K |
$140.91K |
30.70K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
30700 |
$4.59 |
$140.91K |
|
June 9th, 2022 |
Christopher Cain |
|
Stock Award
|
30.70K |
$- |
30.70K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
30700 |
$0.00 |
$- |
|
June 9th, 2022 |
Peter Harwin |
|
Stock Award
|
30.70K |
$- |
30.70K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
30700 |
$0.00 |
$- |
|
June 9th, 2022 |
Peter Harwin |
Director |
Stock Award
|
30.70K |
$140.91K |
30.70K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
30700 |
$4.59 |
$140.91K |
|
June 9th, 2022 |
Todd Shegog |
|
Stock Award
|
30.70K |
$- |
30.70K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
30700 |
$0.00 |
$- |
|
April 5th, 2022 |
Karen Ferrante |
|
Stock Award
|
2.75K |
$13.38K |
2.75K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
2753 |
$4.86 |
$13.38K |
|
April 5th, 2022 |
Karen Ferrante |
Director |
Stock Award
|
2.75K |
$21.80K |
2.75K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
2753 |
$7.92 |
$21.80K |
|
April 5th, 2022 |
Matthew Ros |
|
Stock Award
|
2.65K |
$12.88K |
2.65K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
2650 |
$4.86 |
$12.88K |
|
April 5th, 2022 |
Matthew Ros |
Director |
Stock Award
|
2.65K |
$20.99K |
2.65K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
2650 |
$7.92 |
$20.99K |
|
January 27th, 2022 |
John Green |
Chief Financial Officer |
Stock Award
|
225.00K |
$1.71M |
225.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
225000 |
$7.60 |
$1.71M |
|
January 27th, 2022 |
Jessica Sachs |
Chief Medical Officer |
Stock Award
|
250.00K |
$1.90M |
250.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
250000 |
$7.60 |
$1.90M |
|
January 27th, 2022 |
Evan Kearns |
Chief Legal Officer |
Stock Award
|
202.25K |
$1.54M |
202.25K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
202250 |
$7.60 |
$1.54M |
|
January 27th, 2022 |
John Robinson |
Chief Scientific Officer |
Stock Award
|
250.00K |
$1.90M |
250.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
250000 |
$7.60 |
$1.90M |
|
January 27th, 2022 |
Andrew Robbins |
Director, Officer: President And CEO |
Stock Award
|
690.00K |
$5.24M |
690.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
690000 |
$7.60 |
$5.24M |
|
January 4th, 2022 |
Jessica Sachs |
Chief Medical Officer |
Stock Award
|
674 |
$4.59K |
674 |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
674 |
$6.82 |
$4.59K |
|
January 4th, 2022 |
Karen Ferrante |
Director |
Stock Award
|
2.33K |
$20.26K |
2.33K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
2329 |
$8.70 |
$20.26K |
|
January 4th, 2022 |
Matthew Ros |
Director |
Stock Award
|
2.26K |
$19.63K |
2.26K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
2256 |
$8.70 |
$19.63K |
|
October 5th, 2021 |
Karen Ferrante |
Director |
Stock Award
|
2.38K |
$20.37K |
2.38K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
2385 |
$8.54 |
$20.37K |
|
October 5th, 2021 |
Matthew Ros |
Director |
Stock Award
|
2.46K |
$21.03K |
2.46K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
2463 |
$8.54 |
$21.03K |
|
July 6th, 2021 |
Matthew Ros |
Director |
Stock Award
|
2.23K |
$17.84K |
2.23K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
2225 |
$8.02 |
$17.84K |
|
July 6th, 2021 |
Karen Ferrante |
Director |
Stock Award
|
2.51K |
$20.15K |
2.51K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
2513 |
$8.02 |
$20.15K |
|
May 5th, 2021 |
Evan Kearns |
Chief Legal Officer |
Stock Award
|
260.00K |
$2.32M |
260.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
260000 |
$8.93 |
$2.32M |
|
May 5th, 2021 |
Evan Kearns |
Officer |
|
- |
$- |
- |
Form 3
|
Security |
Transaction |
Shares |
Price |
Value |
|
|
0 |
$0.00 |
$- |
|
April 28th, 2021 |
John Green |
Chief Financial Officer |
Sale
|
17.81K |
$157.82K |
3.84K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
17813 |
$8.86 |
$157.82K |
|
April 28th, 2021 |
John Green |
Chief Financial Officer |
Sale
|
17.81K |
$157.82K |
3.84K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
17813 |
$8.86 |
$157.82K |
|
April 15th, 2021 |
John Robinson |
Chief Scientific Officer |
|
500.00K |
$4.39M |
- |
Form 3
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
|
500000 |
$8.78 |
$4.39M |
|
April 5th, 2021 |
Karen Ferrante |
Director |
Stock Award
|
2.12K |
$19.26K |
2.12K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
2121 |
$9.08 |
$19.26K |
|
April 5th, 2021 |
Matthew Ros |
Director |
Stock Award
|
2.07K |
$18.78K |
2.07K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
2068 |
$9.08 |
$18.78K |
|
March 15th, 2021 |
Peter Harwin |
Director |
Stock Award
|
60.00K |
$507.00K |
60.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
60000 |
$8.45 |
$507.00K |
|
March 15th, 2021 |
Karen Ferrante |
Director |
Stock Award
|
60.00K |
$507.00K |
60.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
60000 |
$8.45 |
$507.00K |
|
March 15th, 2021 |
Todd Shegog |
Director |
Stock Award
|
22.50K |
$190.12K |
22.50K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
22500 |
$8.45 |
$190.12K |
|
March 15th, 2021 |
Matthew Ros |
Director |
Stock Award
|
60.00K |
$507.00K |
60.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
60000 |
$8.45 |
$507.00K |
|
March 15th, 2021 |
Matthew Ros |
Director |
Stock Award
|
60.00K |
$507.00K |
60.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
60000 |
$8.45 |
$507.00K |
|
March 15th, 2021 |
Christopher Cain |
Director |
Stock Award
|
60.00K |
$507.00K |
60.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (Right to Buy) |
Stock Award
|
60000 |
$8.45 |
$507.00K |
|